Cellular Origins and Fresenius Kabi completed integration of Fresenius Kabi’s Cue R Cell Processing System into Cellular Origins’ Constellation R CGT robotic manufacturing platform, marking the first-phase milestone in their automation collaboration. The teams validated workflows with human T cells and confirmed reduced manual intervention across processes. Executives framed the integration as essential to scaling cell and gene therapy manufacturing by lowering cost, variability and human error. The milestone aims to support end‑to‑end robotic automation that preserves existing clinical workflows while enabling higher throughput for commercial supply.